Ravi Rajpoot, MD

Clinical Fellow

Publications

Shukla R, Ramasamy V, Rajpoot RK, Arora U, Poddar A, Ahuja R, Beesetti H, Swaminathan S, Khanna N. Next generation designer virus-like particle vaccines for dengue. Expert Rev Vaccines. 2019 02; 18(2):105-117.
Rajpoot RK, Shukla R, Arora U, Swaminathan S, Khanna N. Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice. Sci Rep. 2018 Jun 05; 8(1):8643.
Shukla R, Rajpoot RK, Arora U, Poddar A, Swaminathan S, Khanna N. Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo. Front Microbiol. 2017; 8:2644.
Alam P, Beg AZ, Siddiqi MK, Chaturvedi SK, Rajpoot RK, Ajmal MR, Zaman M, Abdelhameed AS, Khan RH. Ascorbic acid inhibits human insulin aggregation and protects against amyloid induced cytotoxicity. Arch Biochem Biophys. 2017 05 01; 621:54-62.
Khetarpal N, Shukla R, Rajpoot RK, Poddar A, Pal M, Swaminathan S, Arora U, Khanna N. Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies. Am J Trop Med Hyg. 2017 Jan 11; 96(1):126-134.
Knipping S, Rajpoot R, Houshyar R. Choledochoduodenal fistula in the setting of Crohn's disease. Radiol Case Rep. 2016 Dec; 11(4):309-312.
Poddar A, Ramasamy V, Shukla R, Rajpoot RK, Arora U, Jain SK, Swaminathan S, Khanna N. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies. BMC Biotechnol. 2016 06 14; 16(1):50.
Alam P, Chaturvedi SK, Siddiqi MK, Rajpoot RK, Ajmal MR, Zaman M, Khan RH. Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases. Sci Rep. 2016 05 27; 6:26759.
Alam P, Abdelhameed AS, Rajpoot RK, Khan RH. Interplay of multiple interaction forces: Binding of tyrosine kinase inhibitor nintedanib with human serum albumin. J Photochem Photobiol B. 2016 Apr; 157:70-6.